Pro Bitcoin traders' view on BTC’s flash crash to $112.6K: Did anything change?
Bitcoin derivatives markets show heightened caution amid weak macroeconomic data, but Bitcoin ETF inflows and corporate accumulation signal bullishness. Source
Read More
Author: Abraham
Trade of the Day: Gold Fields (GFI) Stock Offers a Contrarian Opportunity
Source: aerogondo2 / Shutterstock.com While the precious metals complex largely enjoyed a positive session on Monday thanks to gold’s spot
Read More
Did Bitcoin just finish its 8-week delay in copying gold's all-time highs?
Bitcoin traded revealed that BTC price action could be ready to follow gold to new all-time highs after bulls held
Read More
Cisco Layoffs 2024: What to Know About the Latest Job Cuts at CSCO
Source: Valeriya Zankovych / Shutterstock.com Cisco (NASDAQ:CSCO) is among the large-cap tech stocks that investors may not necessarily pay as
Read More
Massachusetts to hold hearing to consider Bitcoin reserve bill
Introduced by a Republican lawmaker in February, the legislation may be unlikely to get any traction in the Massachusetts legislature,
Read More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday and we have all of the biggest stories traders need to
Read More
How to use ChatGPT to find hidden gems in the crypto market
Discover hidden crypto gems using ChatGPT: GPTs, sentiment insights and data-driven scanners for smarter research and trading. Source Link
Read More
Why Is Digital Ally (DGLY) Stock Up 82% Today?
Source: rafapress / Shutterstock Digital Ally (NASDAQ:DGLY) stock is on the rise Wednesday alongside heavy pre-market trading of the digital video
Read More
Price predictions 9/29: SPX, DXY, BTC, ETH, XRP, BNB, SOL, DOGE, ADA, HYPE
Bulls lift their short-term Bitcoin price target to $117,500 as BTC holds steady and several altcoins reclaim the pre-crash trading
Read More
Why Is Viracta Therapeutics (VIRX) Stock Up 42% Today?
Source: Shutterstock / PopTika Viracta Therapeutics (NASDAQ:VIRX) stock is heading higher on Wednesday after the clinical-stage precision oncology company released its
Read More